297172-16-8 Usage
General Description
4-Hydroxymethyl-4-methylpiperidine, also known as 4-Hydroxy-4-methylpiperidine, is a chemical compound with the molecular formula C6H13NO. It is a derivative of piperidine and is commonly used in the pharmaceutical industry as an intermediate for the synthesis of various drugs and pharmaceuticals. 4-Hydroxymethyl-4-methylpiperidine has been studied for its potential use in the treatment of central nervous system disorders and has shown promise in preclinical trials as an antipsychotic and antidepressant agent. Additionally, 4-Hydroxymethyl-4-methylpiperidine has been investigated for its potential as a reagent in organic chemistry and has been used as a building block for the synthesis of other chemical compounds.
Check Digit Verification of cas no
The CAS Registry Mumber 297172-16-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,9,7,1,7 and 2 respectively; the second part has 2 digits, 1 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 297172-16:
(8*2)+(7*9)+(6*7)+(5*1)+(4*7)+(3*2)+(2*1)+(1*6)=168
168 % 10 = 8
So 297172-16-8 is a valid CAS Registry Number.
InChI:InChI=1/C7H15NO/c1-7(6-9)2-4-8-5-3-7/h8-9H,2-6H2,1H3
297172-16-8Relevant articles and documents
N-ACYL-{4-[(4-ARYL-PHENYL)SULFONYLMETHYL]PIPERIDINE} COMPOUNDS AND THEIR THERAPEUTIC USE
-
Page/Page column 118; 119, (2020/10/28)
The present invention pertains generally to the field of therapeutic compounds. More specifically the present invention pertains to certain N-acyl-{4-[(4-aryl- phenyl)sulfonylmethyl]piperidine} compounds of the following formula (collectively referred to
HEPATITIS B ANTIVIRAL AGENTS
-
Page/Page column 197, (2013/07/05)
The present invention includes a method of inhibiting, suppressing or preventing HBV infection in an individual in need thereof, comprising administering to the individual a therapeutically effective amount of at least one compound of the invention.
Modulators of muscarinic receptors
-
Page/Page column 120, (2010/11/29)
The present invention relates to modulators of muscarinic receptors. The present invention also provides compositions comprising such modulators, and methods therewith for treating muscarinic receptor mediated diseases.